Published in Medical Letter on the CDC and FDA, July 23rd, 2006
Novartis Consumer Health also announced that it is conducting a nationwide voluntary recall of all Triaminic Vapor Patch products.
FDA is advising consumers who have used the product and have concerns or questions to contact their physician or health care practitioner. In addition, the company is advising consumers to either discard or return the product to their point of purchase for a refund.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA